BioMensio’s bio-screening sensor finds funding
BioMensio, a biotechnology company based in Tampere, has landed 2.5 million euros in funding to develop a handheld bio-screening sensor which can detect the presence of specific biomolecules.
The funding for the handheld bio-screening sensor and associated services comes from private investors, Siemens Technology Accelerator and Tekes, the Finnish Funding Agency for Innovation. Also contributing to the funding round was VTT Ventures, the venture arm of VTT Technical Research Centre Finland investing in VTT’s most promising new technologies.
“BioMensio is now set to develop a smart handheld bio-screening sensor and associated cloud services to determine the presence of specific biomolecules,” CEO of BioMensio, Ilari Antila explains. “Rapid and accurate on-site testing enables fast and targeted action in the presence of multiple unwanted substances from a biological liquid based sample.”
What makes BioMensio’s bio-screening sensor stand out is how it works without having to resort to labelling or analyte modifications as with traditional techniques.
As to where to put the sensor to good use, Antila points to plenty of possibilities, “The BioMensio biosensors allow cost efficient application development for businesses and governmental organisations in food and beverage, healthcare, security and defence segments as well as environmental monitoring area.”